N-ACetylcysteine to Reduce Infection and Mortality for Alcoholic Hepatitis
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Alcoholic Hepatitis
- Infection
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: randomized controlled trialMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Randomised controlled trial, open label.
Randomised controlled trial, open label.
Tracking Information
- NCT #
- NCT03069300
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Mark Thursz, MD Imperial College London
Get Well Soon